Trimethobenzamide Hydrochloride
Active substance: trimethobenzamide
CAPSULE · TRIMETHOBENZAMIDE HYDROCHLORIDE 300 mg/1
United StatesActive
Marketing holder: Lupin Pharmaceuticals,Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRIMETHOBENZAMIDE HYDROCHLORIDE · 300 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4cdc-7379-a76a-378764d56b89,01a1208c-5d65-7c48-a0e0-918bcb1bb78f,01a1208c-bc87-7762-b4ad-d97a340281bd,01a1208c-c263-7a71-9bd6-24c8e7fb12d3,01a12096-9ada-7db5-bf0e-8799c8b19356;count=8 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43386-660
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 43386-660 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43386-660 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43386-660 · Verified 2026-10-09 · open in source